Summary by Futu AI
On June 21, 2024, Innovent Bio held its annual shareholder meeting, at which resolutions such as the adoption of financial statements, director reelection, and charter revisions were passed. All directors attended the meeting in person or electronically, including Chairman and CEO Dr. Yu Dechao, Executive Director Mr. Xi Hao, Ms. Zhang Qian, and independent non-executive director Dr. Charles Leland Cooney. Ordinary resolutions at the annual shareholder meeting included approving the audited financial statements for the year ended December 31, 2023, reelecting directors, reappointing auditors, authorizing directors to repurchase and issue shares, etc., all of which were officially passed with over 50% of the votes in favor. The special resolution was to adopt the charter and bylaws revised and restated for the 15th time, which was passed with over 75% of the votes in favor. The voting results of the annual shareholder meeting showed that the company's governance and future development direction received broad support from shareholders.
